01 1Eurofins CDMO Alphora Inc
02 1Piramal Pharma Solutions Inc.
01 1Rabacfosadine Succinate
02 1rabacfosadine succinate
01 1France
02 1U.S.A
NDC Package Code : 43076-010
Start Marketing Date : 2018-01-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 58621-006
Start Marketing Date : 2017-04-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (16.4mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
54
PharmaCompass offers a list of Rabacfosadine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rabacfosadine manufacturer or Rabacfosadine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rabacfosadine manufacturer or Rabacfosadine supplier.
A Rabacfosadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rabacfosadine, including repackagers and relabelers. The FDA regulates Rabacfosadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rabacfosadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rabacfosadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Rabacfosadine supplier is an individual or a company that provides Rabacfosadine active pharmaceutical ingredient (API) or Rabacfosadine finished formulations upon request. The Rabacfosadine suppliers may include Rabacfosadine API manufacturers, exporters, distributors and traders.
click here to find a list of Rabacfosadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rabacfosadine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rabacfosadine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rabacfosadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rabacfosadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rabacfosadine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rabacfosadine suppliers with NDC on PharmaCompass.
We have 2 companies offering Rabacfosadine
Get in contact with the supplier of your choice:
